Choksi Laboratories Ltd (526546) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 526546 | NSE: | Hospital & Healthcare Services | Small Cap

Choksi Lab Share Price

118.40 -3.65 -2.99%
as on 05-Dec'25 16:59

Choksi Laboratories Ltd (526546) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 526546 | NSE: | Hospital & Healthcare Services | Small Cap

DeciZen - make an informed investing decision on Choksi Lab

Based on:

M-Cap below 100cr DeciZen not available

Choksi Laboratories stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
51.46
Market Cap:
85 Cr.
52-wk low:
60.2
52-wk high:
236.7

Is Choksi Laboratories Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Choksi Lab: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Choksi Laboratories Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 7.3%8.4%10.5%10.1%-8.3%0%6.8%13.9%9.2%9.5%-
Value Creation
Index
-0.5-0.4-0.3-0.3-1.6-1.0-0.50.0-0.3-0.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 22.328.831.233.828.225.73034.436.741.844
Sales YoY Gr.-29%8.5%8.2%-16.6%-8.8%16.9%14.7%6.6%13.8%-
Adj EPS 1.20.91.92.3-2.4-3.70.32.31.62.22.4
YoY Gr.--20.7%110.9%18%-206.1%NANA673.3%-31%36.3%-
BVPS (₹) 28.830.332.234.52925.525.730.331.933.935.2
Adj Net
Profit
0.80.61.41.6-1.7-2.60.21.61.11.52
Cash Flow from Ops. 6.76.66.36.92.95.97.98.311.611.8-
Debt/CF from Ops. 21.722.4116.14.43.72.52.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 7.2%8.2%11.6%13.8%
Adj EPS 7.3%NA93.7%36.3%
BVPS1.8%3.1%9.7%6.3%
Share Price 23.4% 59.4% 48.7% 76.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
4.13.16.26.9-7.7-13.71.28.35.26.66.9
Op. Profit
Mgn %
23.316.620.321.512.616.129.729.82827.127
Net Profit
Mgn %
3.62.24.34.7-6-10.10.74.733.63.7
Debt to
Equity
0.70.50.60.71.621.91.41.31.20.6
Working Cap
Days
24418114917422121917115014213668
Cash Conv.
Cycle
652613851944727046-28

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Choksi Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 2.4 -
TTM Sales (₹ Cr.) 44.1 -
BVPS (₹.) 35.2 -
Reserves (₹ Cr.) 18 -
P/BV 3.47 -
PE 51.46 -
From the Market
52 Week Low / High (₹) 60.21 / 236.70
All Time Low / High (₹) 0.50 / 236.70
Market Cap (₹ Cr.) 85
Equity (₹ Cr.) 7
Face Value (₹) 10
Industry PE 90.5

Management X-Ray of Choksi Lab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Choksi Lab - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Choksi Lab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales22.3028.7631.2033.7528.1625.6930.0434.4436.7041.78
Operating Expenses 17.2223.9824.8726.4825.3221.5621.1424.1826.4230.47
Manufacturing Costs2.773.373.923.823.883.753.544.334.675.51
Material Costs2.822.973.473.953.242.571.982.212.563.10
Employee Cost 7.298.7610.5111.4711.7010.7811.041213.0315.22
Other Costs 4.338.876.977.246.504.464.575.636.166.65
Operating Profit 5.084.786.337.262.844.138.9110.2610.2711.31
Operating Profit Margin (%) 22.8%16.6%20.3%21.5%10.1%16.1%29.6%29.8%28.0%27.1%
Other Income 0.010.860.360.250.330.490.120.220.160.07
Interest 1.231.471.591.541.892.823.233.523.062.72
Depreciation 2.732.863.163.684.564.605.435.505.716.50
Exceptional Items 0000-2.43002.2600
Profit Before Tax 1.141.311.932.29-5.71-2.810.373.721.662.15
Tax 0.420.420.590.69-1.83-0.200.160.510.550.63
Profit After Tax 0.720.891.351.60-3.88-2.610.213.211.111.52
PAT Margin (%) 3.2%3.1%4.3%4.7%-13.8%-10.2%0.7%9.3%3.0%3.6%
Adjusted EPS (₹)1.01.31.92.3-5.6-3.70.34.61.62.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 20.0321.1322.4024.0120.2217.7517.9021.1122.2123.60
Share Capital 6.976.976.976.976.976.976.976.976.976.97
Reserves 13.0714.1615.4317.0413.2610.7810.9414.1415.2516.64
Minority Interest0000000000
Debt10.898.039.8615.1229.8531.2930.0325.2123.8321.75
Long Term Debt8.064.275.521427.3628.8227.5423.611815.23
Short Term Debt2.823.764.341.122.492.482.491.595.846.52
Trade Payables4.014.815.657.156.424.834.021.803.935.43
Others Liabilities 7.606.686.779.077.1410.9811.0811.3711.5814
Total Liabilities 42.5340.6644.6855.3563.6364.8563.0359.4961.5664.79

Fixed Assets

Gross Block28.5222.4331.6544.4845.9467.5668.7170.9474.3184.72
Accumulated Depreciation10.882.866.039.6812.8617.2422.1526.1130.8837.10
Net Fixed Assets 17.6419.5625.6334.8133.0850.3246.5644.8343.4347.61
CWIP 8.994.2803.2313.060.501.670.312.990
Investments 02.672.990000000
Inventories00.230.290.410.180.110.250.210.360.56
Trade Receivables8.588.809.888.796.998.1610.2910.6510.3911.27
Cash Equivalents 0.920.560.950.230.430.310.410.340.660.61
Others Assets 6.394.554.947.899.905.443.853.153.724.73
Total Assets 42.5340.6644.6855.3563.6364.8563.0359.4961.5664.79

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 6.716.576.256.912.875.907.888.2511.5511.78
PBT 1.141.311.932.29-5.71-2.810.373.721.662.15
Adjustment 43.674.294.997.086.938.726.908.789.43
Changes in Working Capital 3.370.931.662.682.57-1.34-2.39-3.111.62.19
Tax Paid -1.800.66-1.64-3.07-1.073.111.170.74-0.49-2
Cash Flow From Investing Activity -7.40-1.88-4.91-9.76-13.76-7.65-2.71-0.71-6.65-7.61
Capex -1.15-2.28-4.83-6.51-1.44-7.54-1.13-0.89-4.35-7.68
Net Investments 00-0.3200000.010.190.02
Others -6.250.400.24-3.25-12.33-0.10-1.580.17-2.490.06
Cash Flow From Financing Activity 0.80-4.89-0.942.1311.091.63-5.07-7.61-4.58-4.22
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 2.16-3.420.653.6713.394.73-1.46-3.51-5.36-2.04
Interest Paid -1.23-1.47-1.59-1.54-1.89-2.77-3.21-3.49-3.01-2.65
Dividend Paid 0000000000
Others -0.14-0-0-0-0.41-0.32-0.40-0.613.780.47
Net Cash Flow 0.11-0.200.40-0.720.20-0.120.10-0.070.32-0.04

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)3.674.346.196.9-17.57-13.741.1616.465.126.65
ROCE (%)7.328.4110.4910.14-8.270.026.7513.99.189.45
Asset Turnover Ratio0.560.690.830.670.470.40.470.560.610.66
PAT to CFO Conversion(x)9.327.384.634.32N/AN/A37.522.5710.417.75
Working Capital Days
Receivable Days1391109710110210811211110595
Inventory Days0334422234
Payable Days432541550592764801814480409551

Choksi Laboratories Ltd Stock News

Choksi Laboratories Ltd FAQs

The current trading price of Choksi Lab on 05-Dec-2025 16:59 is ₹118.4.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Choksi Lab stood at ₹85.01.
The latest P/E ratio of Choksi Lab as of 04-Dec-2025 is 51.46.
The latest P/B ratio of Choksi Lab as of 04-Dec-2025 is 3.47.
The 52-week high of Choksi Lab is ₹236.7 and the 52-week low is ₹60.21.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Choksi Lab is ₹44.14 ( Cr.) .

About Choksi Laboratories Ltd

Established in 1982, Choksi Laboratories Limited (CLL), is more widely known as a leading analysis and research group, providing complete solutions for improving quality in processes, products and services.

CLL is a contract testing and analysis laboratory based in Indore, Central India. It analyzes, for its clients, or as a regulatory requirement, pharmaceuticals, food and agricultural products, construction materials, chemicals etc. It also help industries in their research processes. Its environment consultancy division helps firms in keeping the environment clean and free from pollution.

CLL was the first to develop Vendor Assessment programme in the edible oil extraction industry. The first to start water and soil analysis in Central India, also the first to start instrument calibration services for organizations that were targeting ISO certification or had already achieved it. The only one to commission and run, probably the largest Effluent Treatment Plant in India, at ONGC's Amod oil rig.

Quality products are a function of better raw materials and quality procedures.  CLL currently has facilities for analysis of over 1000 products and materials, with more being added every day.

A vast updated database of test specifications derived from AOAC, USP, BP, CP, EP, IP, IS, EPA, PFA, Food Chemicals Codex, AOCS, and several in-house methods, serves a wide spectrum of products and materials – pharmaceutical raw materials and formulations, agro products and their derivatives, fertilizers, pesticides, edible and industrial oils, chemicals, paints and dyes.

Last year, CLL provided its services to more than 1,000 customers world-wide. Driving this accelerated growth is a hard-working people-force of 200+ CLL personnel. They are young (The average age in CLL is below 30 years). They are determined. And they have a huge appetite for learning. Mostly from the University town of Indore, these graduates undergo a rigorous six month training at their lab. Once inducted, continuous training programmes take over - both internal as well as external. And finally the long painful process of getting these qualified personnel approved as FDA, BIS, MoEF - whatever their respective fields demand. In fact, one thing that they are quite known for is their excellent human resource pool. So much so that the surrounding companies keep playing bait to our experienced staff. Though it is quite a nuisance at times, it also does us proud when they are recognized and accepted in regional companies, and multinationals alike.

Services offered by the company:

  • Contract Laboratory Services (CLS):-Pharmaceutical Analysis-Food & Beverages Analysis-Water Analysis-Construction Material Analysis
  • Instrument Calibration & Validation Services
  • Environment Management Services
  • Clinical Research
  • Consultancy  
  • Assaying & Hallmarking

Clientele:

  • IPCA Laboratories
  • Nicholas Piramal India Ltd.
  • Serum Institute of India
  • Famycare India

Achievements/ recognition:

  • CLL is certified by BIS (Bureau of Indian Standards), FDA (Food and Drugs control Administration), MoEF (Ministry of Environment & Forests), State Pollution Control Boards (Gujarat and Madhya Pradesh State Pollution Control Boards), Department of Health(MP), Agricultural Marketing Advisor (AGMARK - GOI), and several other regulatory bodies.
  • CLL has also been accredited by NABL (National Accreditation Board for testing & calibration Laboratories). This is internationally recognized through ILAC (International Laboratory Accreditation Committee) and is based on ISO/IEC 17025 guidelines.
  • ISO/IEC 17025 : 2005Ministry of Environment & Forests (MoEF), India
  • Bureau of Indian Standards (BIS), India
  • Export Inspection Council (EIC), India
  • AGMARK, IndiaGold & Silver Assaying & Hallmarking Center (approved by Bureau of Indian Standards)
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×